Cargando…
Case Report: Unmasked Inherited Dysfibrinogenemia After Everolimus Therapy
A previously hemostatically asymptomatic patient with common variable hypogammaglobulinemia was given everolimus to prevent growth of her liver. Within several months, the patient developed a severe bleeding disorder. The bleeding was due to fibrin polymerization defect that upon sequencing was show...
Autores principales: | Merkulova, Alona A., Mitchell, Steven C., Merkulov, Sergei, Wolberg, Alisa S., Neerman-Arbez, Marguerite, Schmaier, Alvin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729062/ https://www.ncbi.nlm.nih.gov/pubmed/33330551 http://dx.doi.org/10.3389/fmed.2020.591546 |
Ejemplares similares
-
Pseudohomozygous dysfibrinogenemia
por: Peck, Rachel C., et al.
Publicado: (2021) -
A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease
por: Gittleman, Haley R., et al.
Publicado: (2016) -
Clinical Consequences and Molecular Bases of Low Fibrinogen Levels
por: Neerman-Arbez, Marguerite, et al.
Publicado: (2018) -
Acute renal artery infarction secondary to dysfibrinogenemia
por: Keinath, Kyle, et al.
Publicado: (2017) -
Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020)